Bnp Paribas Issuer Callable Point to Point Barrier Note Ablkexx (ABLKEXX)

NWBO could file an FDA application anytime but they haven't and have shown no intent to do so. Instead they are just burning more shareholder cash and if approved, will lose money on every dose because NICE will hammer the reimbursement down below Advent's costs. NWBO will lose money and collaps

TotalEnergies SE: Disclosure of Transactions in Own SharesJune 16, 2026 2:00 AM
Business Wire Regulatory News In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share

Sorry, not enough. NWBO won't make any profit selling in the UK. NICE hates personalized oncology treatments and won't pay enough for NWBO to make a profit.
That's what counts. And NWBO will go under or just become Advent Contract Manufacturer. They have no cash or credit to fund any sub

Don’t start spazzing again, Alteogen circus clown. The Sanofi news is old.
Once Merck settles/licenses from Halozyme, Sanofi and all others will follow.
Your Alteogen stole IP from Halozyme and will pay a price for it. You can count on it.
The companies who have signed with Alte

Your theory will be put to the test after UK approval. I give it 6 months as a guess.

What's true is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How many years are you going to wait to find out???

What's True is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How long are you going to wait to find out???

Google Scholar alert - new article: "A Comparison of Plasmonic Modulator Structures in the O- and C-Band for the 400G/Lane IM/DD Era"
>>> " In ALL cases, the same electro-optic organic material, Lightwave Logic’s PerkinamineTM
chromophore series 3, was used " !
https://ieeexplor

Stop talking nonsense. Sanofi is conducting clinical trials using Alteogen's technology; what are your thoughts on this? Did you sense a crisis for Halozyme?

I love it when Alteogen fanboys post on this board. Nearly every time they show up, Halozyme has a run up. 

Prophecy is coming

https://www.cnbc.com/2026/06/16/boj-rate-hike-historic-inflation.html

Japanese rates are going higher

Yen is yet to be stabilize

The great unwinding is coming soon

GLTA

Authorized Shares 1,800,000,000 06/15/2026
Outstanding Shares 1,619,034,363 06/15/2026 >5m
Restricted 480,530,670 06/15/2026 >5m
Unrestricted 1,138,503,693 06/15/2026
Held at DTC 1,011,499,104 06/15/2026 >8m

Authorized Shares 1,800,000,000 06/05/2026

One has to question why a “cash rich” company would need to raise $20-25 billion by going to bond sales that will be in 7 tranches, ranging from 2 to 30 years. The statement is that it’s for general purposes and to redo some current debt financing.

Based on recent financials, NVDA’

FACT CHECK:


The key distinction is between “eligible” and “selected.”


To date, CMS has not publicly released a list of approved CBD brands for the Substance Access Beneficiary Engagement Incentive (BEI) program.


That means:

Your Mother should've named you loser0. Awww did someone take your lunch money in school loser0? IMO

Great.. thank you.

Pivot Calcs: SPX Pivot 7549---R1 7582---S1 7521---SPY Pivot 754---R1 757---S1 752----ES Pivot 7601---R1 7667---S1 7555----VIX Pivot 16.35---R1 16.70---S1 15.85---15 min Bull/Bear R/Line 18.34!----!!LOL!!

Are you for real loser0? You always hide behind a computer screen loser0? IMO

WQLF SAYS: .Charlottes Web products Have Not been PUBLICLY STATED as being OFFICIALLY APPROVED. In the case of CV SCIENCES, the CMS Pilot Program still has time to Announce CV SCIENCES or are they already enrolled? Cornbread was never announced, so one can not reliably state that it is A True FACT Y

Wow, that would be fantastic. It would be a dream come true for me after the many losses (FORW, BLEG, PAVS) this year... I have to admit, the latest news was fantastic; the company shouldn't be trading at this level and could soon see a massive surge—similar to how QBTS went from $0.50 to $20 years

$GPUS GPUS should make a magnificent, big, and sustained climb now; we just need a little patience, the ability to weather the fluctuations (ups and downs), and steady nerves. Ultimately, however, we should be trading in the multi-dollar range., all only imho


many great news &

And why would we own this pos? You act like us knowing this is not a good investment is a bad thing?

$GPUS GPUS should make a magnificent, big, and sustained climb now; we just need a little patience, the ability to weather the fluctuations (ups and downs), and steady nerves. Ultimately, however, we should be trading in the multi-dollar range., all only imho

$GPUS many great news 🔥 strong undervalued https://www.otcmarkets.com/stock/GPUS/news

OTC Market Seite

https://www.otcmarkets.com/stock/GPUS/profile